Apintus Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 58.99%
(FY 2023)
- Ebitda 58.99%
(FY 2023)
- Net Worth -0.46%
(FY 2023)
- Total Assets -42.87%
(FY 2023)
About Apintus Labs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manohar Bommanpad, Satish Varma, and Shailaja Manohar serve as directors at the Company.
- CIN/LLPIN
U24100MH2015PTC264861
- Company No.
264861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Apintus Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Bommanpad  | Director | 09-May-2016 | Current |
| Satish Varma | Director | 26-May-2015 | Current |
| Shailaja Manohar | Director | 26-May-2015 | Current |
Financial Performance of Apintus Labs.
Apintus Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 58.99% increase in profit. The company's net worth dipped by a decrease of 0.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apintus Labs?
In 2023, Apintus Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivan Life Sciences Private LimitedActive 14 years 8 monthsManohar Bommanpad, Satish Varma and 1 more are mutual person
Vivan Advanced Chemicals Lab Private LimitedActive 1 year 5 monthsManohar Bommanpad and Shailaja Manohar are mutual person
- Shcova Laboratories Private LimitedActive 12 years 4 months
Satish Varma and Shailaja Manohar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apintus Labs?
Apintus Labs has a workforce of 7 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apintus Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apintus Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
